Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Factor VIII hyperactivity: an arterio-venous thrombogenic factor. Case report].

S L Bennani1, B Vaquette, D Pavin

  • 1Département de cardiologie et maladies vasculaires, Centre cardio-pneumologique niveau 6, hôpital Pontchaillou, CHU, 35033 Rennes.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart rate differences between symptomatic and asymptomatic Brugada syndrome patients at night.

Physiological measurement·2018
Same author

Heart rate complexity analysis in Brugada syndrome during physical stress testing.

Physiological measurement·2017
Same author

Prognostic value of left atrial reservoir function in patients with severe aortic stenosis: a 2D speckle-tracking echocardiographic study.

European heart journal. Cardiovascular Imaging·2015
Same author

Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2014
Same author

Are electronic cardiac devices still evolving?

Yearbook of medical informatics·2014
Same author

Coronary angioplasty is associated with a better neurological outcome in the era of modern management of out-of-hospital cardiac arrest.

International journal of cardiology·2013

Factor VIII hyperactivity is a risk factor for thrombosis, particularly in coronary artery disease. This case highlights the understudied pro-thrombotic role of factor VIII in patients with a history of thrombotic events.

Area of Science:

  • Vascular pathology and thrombosis research.

Background:

  • Thrombosis is a key factor in cerebral, coronary, and peripheral vascular diseases.
  • Coagulation factors play a critical role in atherothrombotic lesion development.
  • Elevated pro-coagulant factors increase thrombosis risk.

Observation:

  • Factor VIII, a pro-coagulant factor, has been minimally studied for its thrombogenic potential.
  • A 62-year-old patient with a history of arterial and venous thromboses presented with myocardial infarction.
  • Factor VIII hyperactivity was identified in this patient post-myocardial infarction.

Findings:

  • This case demonstrates a link between factor VIII complex hyperactivity and thrombosis.
  • Factor VIII hyperactivity was associated with recurrent arterial and venous thrombotic episodes.

Related Experiment Videos

  • The patient's condition suggests a significant role for factor VIII in coronary pathology.

    • Implications:

    • Factor VIII hyperactivity should be considered in patients with unexplained or recurrent thrombosis.
    • Further research into factor VIII's pro-thrombotic mechanisms is warranted.
    • Understanding factor VIII's role may lead to improved prevention and treatment strategies for thrombotic diseases, especially coronary artery disease.